Dewpoint is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint develops drugs for the vast range of conditions that are regulated by condensates or arise from the dysfunction of condensates. Dewpoint currently has multiple programs across an ambitious pipeline spanning oncology, neurodegeneration, cardiopulmonary, and virology indications, and collaborations with leading global academic and pharmaceutical partners, including Bayer, Merck, and Pfizer. Dewpoint scientists work in Boston, Dresden and Frankfurt to translate condensate biology into breakthrough treatments for diseases previously considered untreatable.
View Top Employees from Dewpoint TherapeuticsWebsite | https://dewpointx.com |
Employees | 141 (135 on RocketReach) |
Founded | 2018 |
Address | 451 D Street Suite 104, Boston, Massachusetts 02210, US |
Technologies |
JavaScript,
HTML,
Twitter
+25 more
(view full list)
|
Industry | Biotechnology Research |
Looking for a particular Dewpoint Therapeutics employee's phone or email?
Lori Escobedo is the Chief People Officer of Dewpoint Therapeutics.
135 people are employed at Dewpoint Therapeutics.
Dewpoint Therapeutics is based in Boston, Massachusetts.